In the course of our continuing search for antifungal antibiotics from microbial sources, we found an antifungal antibiotic against phytopathogenic fungi, especially Alternaria sp. from Actinomycete strain NPO-101. In the present report, we describe fermentation, isolation, physico-chemical properties, structure elucidation, and biological activities of NP-101A. The producing organism, strain NPO-101, was isolated from a soil sample collected in Sapporo, Hokkaido, Japan. The taxonomic characterization was carried out according to the methods used in the International Streptomyces Project (ISP)1}, the method of Pridham and Gottlieb2) and the method of Lechevalier3). The aerial myceliummass color was gray color series. Flexious spore chains were oval-shaped with a smooth surface. Melanoid pigments were produced and hydrolysis of whole-cell of this strain gave ll-DAP. The results of morphological and physiological studies indicated that the strain NPO-101was considered to belong to the genus Streptomyces and to be a strain of the Gray series of the Pridham and Tresner grouping6). According to the method of Kuster's classification^and in the literature description5~8), the strain NPO-101was found to most resemble Streptomyces aurantiogriseus.
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Therefore, this strain was namedStreptomyces aurantiogriseus NPO-101.
A slant culture of Streptomyces aurantiogriseus NPO-101 grown at 27°C for 5days on Hickey-Tresner medium^was inoculated into Sakaguchi flasks containing 100ml of the seed medium composed of glucose lOg, soluble starch 4g, meat extract 3g, yeast extract 5g, tryptone(Bacto) 5 g and CaCO35 g per liter. The pH was adjusted to 7.0 before autoclaving. The flasks were incubated at 27°C for 3days on a reciprocal shaker at 130 strokes per minute. The fermentation was carried out in a 10-liter jar-fermentor. The seed culture (210ml) was transferred into a 10-liter jar-fermentor containing 7 liters of the fermentation medium consisting of glycerol 40g, soybean meal 25g, yeast extract 5g, corn steep liquor powder 1g, NaCl 0.5g and CaCO3 2g per liter. The pH was adjusted to 7.0 prior to autoclaving. The aeration and agitation of the fermentation were maintained at 7liters per minute and 400rpm, respectively, and the temperature at 27°C for 96hours. The antibiotic washed with water followed by 40% MeOHand then antibiotics were eluted with 7liters of 50% MeOH. The eluate was combined and concentrated in vacuo. This material was dissolved in 1liter of water and the pH was adjusted to 7.0 with 1n NaOH. The product was extracted three times with the same volumeof ft-butanol.
The extracts (butanol layers) were concentrated and the residue was subjected to silica gel (Wakogel C-300) column chromatography using a mixture of chloroform : MeOH(9 : 1) as an eluting solvent. The active fractions were combined and evaporated to dryness. The residue was chromatographed on silica gel using chloroform.
The active fractions were combined and concentrated in vacuo and rechromatographed using hexane -acetone eluting solvent (7 : 3). The concentrated active fractions were purified by silica gel PTLCwith benzene : acetone 178.0745 (178.0743 calcd for C9H10N2O2; Table 1 ). The *H and 13C NMRdata ofNP-101A are shown in Table  2 . NP-101A indicated a simple XH NMRspectrum, and there were only four neighbouring aromatic proton signals and acetyl methyl singlet. The 13C NMRand Based on these results, it was concluded that NP-101A is 2-acetamidobenzamide. *H and 13C NMR, and Rf value (0.3, Merck, Kiesegel 60F254: hexane : acetone= 7 : 3 solvent system) of 2-acetamidobenzamide, which was prepared from O-aminobenzamideby acetylation with Ac2O/pyridine, were complete agreement with those ofNP-101A. Thus, the structure of NP-101A was elucidated as 2-acetamidobenzamide. The antibiotic NP-10 1A exhibited antifungal activities against phytopathogenic filamentous fungi (Table 3) , while no activity was observed against Saccharomyces cerevisiae and bacteria, such as Salmonella typhimurium SL3770, Escherichia coli K-12 and Bacillus subtilis.
Benzamide and its derivatives with a substitution at the 3-position have been knownas potent inhibitors of poly(ADP-ribose) synthetaselo'11}. 2-, 3-, and 4-acetamidobenzamidesare also inhibitors of poly(ADPribose) synthetase1 2). However, their antifungal activity has not been reported to date. This is the first report on antifungal activity of 2-acetamidobenzamide, NP-10 1A, as a microbial product. 
